Literature DB >> 18362109

Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes.

Nicolas Leveziel1, Jennyfer Zerbib, Florence Richard, Giuseppe Querques, Gilles Morineau, Veronique Fremeaux-Bacchi, Gabriel Coscas, Gisèle Soubrane, Pascale Benlian, Eric H Souied.   

Abstract

PURPOSE: Major genetic factors for age-related macular degeneration (AMD) have recently been identified as susceptibility risk factors, including polymorphisms of HTRA1 and CFH genes. The purpose was to analyze the angiographic features of patients harboring homozygous genotypes for HTRA1 and CFH genes in a French exudative AMD population.
METHODS: Two hundred patients affected with exudative AMD were genotyped for the polymorphisms rs11200638 of the HTRA1 gene and rs10611710 of the CFH gene. Four homozygous groups were extracted from the entire cohort: double homozygous for wild-type alleles of both genes (group 1), homozygous for the polymorphism of the HTRA1 gene only (group 2), homozygous for the polymorphism of the CFH gene only (group 3), and double homozygous carriers for both polymorphisms (group 4). Choroidal neovascularization (CNV) was graded as classic and predominantly classic (PC), occult, minimally classic (MC), or retinal angiomatosis proliferation (RAP).
RESULTS: Group 1 (n = 9) presented 44.4% classic and PC, 33.3% occult, 11.1% MC, and 11.1% RAP. Group 2 (n = 12) presented 50.0% classic and PC, 33.3% occult, no MC CNV and 16.7% RAP. Group 3 (n = 28) presented 10.7% classic and PC, 67.9% occult, 14.3% MC, and 7.1% RAP. Group 4 (n = 17) presented 29.4% classic and PC, 52.9% occult, 11.8% MC, and 5.9% RAP. Occult CNV or MC CNV was more frequently observed in group 3 than in group 2 (82.1% vs 33.3%; P < 0.02). Classic and PC CNV were more frequently observed in group 2 than in group 3 (50% vs. 10.7%; P < 0.03).
CONCLUSIONS: This attempt at a genotypic-angiographic correlation in an exudative AMD sample suggests an association between occult or MC CNV and the CFH polymorphism and between classic and PC CNV and the HTRA1 polymorphism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362109     DOI: 10.1167/iovs.07-1540

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

Review 1.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

2.  Patient characteristics and treatment of neovascular age-related macular degeneration in France: the LUEUR1 observational study.

Authors:  Salomon-Yves Cohen; Eric H Souied; Michel Weber; Gérard Dupeyron; Gérard de Pouvourville; Michel Lievre; Anne Ponthieux
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-06       Impact factor: 3.117

Review 3.  Genetic predictors of response to photodynamictherapy.

Authors:  Francesco Parmeggiani; Donato Gemmati; Ciro Costagliola; Francesco Semeraro; Paolo Perri; Sergio D'Angelo; Mario R Romano; Katia De Nadai; Adolfo Sebastiani; Carlo Incorvaia
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

4.  Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population.

Authors:  Yongmei Lv; Sumin He; Zheng Zhang; Yang Li; Dayan Hu; Kunju Zhu; Hui Cheng; Fusheng Zhou; Gang Chen; Xiaodong Zheng; Pan Li; Yunqing Ren; Xianyong Yin; Yong Cui; Liangdan Sun; Sen Yang; Xuejun Zhang
Journal:  Rheumatol Int       Date:  2011-09-09       Impact factor: 2.631

5.  Age-related macular degeneration: current treatment and future options.

Authors:  Tanya Moutray; Usha Chakravarthy
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

Review 6.  Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Authors:  Claudio Campa; Ciro Costagliola; Carlo Incorvaia; Carl Sheridan; Francesco Semeraro; Katia De Nadai; Adolfo Sebastiani; Francesco Parmeggiani
Journal:  Mediators Inflamm       Date:  2010-08-25       Impact factor: 4.711

7.  Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Maureen G Maguire; Gui-Shuang Ying; Glenn J Jaffe; Cynthia A Toth; Ebenezer Daniel; Juan Grunwald; Daniel F Martin; Stephanie A Hagstrom
Journal:  JAMA Ophthalmol       Date:  2016-06-01       Impact factor: 7.389

8.  The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples.

Authors:  Jingsheng Tuo; Robert J Ross; George F Reed; Qing Yan; Jie Jin Wang; Christine M Bojanowski; Emily Y Chew; Xiao Feng; Timothy W Olsen; Frederick L Ferris; Paul Mitchell; Chi-Chao Chan
Journal:  Ophthalmology       Date:  2008-08-21       Impact factor: 12.079

9.  Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.

Authors:  Michael T Andreoli; Margaux A Morrison; Ben J Kim; Ling Chen; Scott M Adams; Joan W Miller; Margaret M DeAngelis; Ivana K Kim
Journal:  Am J Ophthalmol       Date:  2009-10-01       Impact factor: 5.258

10.  Biologically active fibronectin fragments stimulate release of MCP-1 and catabolic cytokines from murine retinal pigment epithelium.

Authors:  Bobbie Ann Austin; Baoying Liu; Zhuqing Li; Robert B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.